🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The host response against the coronavirus 2 (SARS-CoV-2) appears to be medi...
Status
Suspended
Location
Hospital La Milagrosa, GenesisCare
Start Date
2020-04-21
Trial ID
NCT04394182
A multicenter, randomized, double-blind, placebo-controlled, and active dru...
Status
Enrolling By Invitation
Location
Peking University People's Hospital
Start Date
2025-04-09
Trial ID
NCT06726096
Treatments Being Tested
This open-label study will evaluate the efficacy and safety of tocilizumab ...
Status
Completed
Location
Aberdeen Royal Infirmary
Start Date
2014-03-04
Trial ID
NCT02046603
Treatments Being Tested
Ever since the biotherapy agents have entered the market, the recommended t...
Status
Completed
Location
CHU Pitié Salpêtrière
Start Date
2012-04
Trial ID
NCT01557374
Treatments Being Tested
Primary Objective: To assess, in the same study, the safety of sarilumab a...
Status
Completed
Location
Investigational Site Number 840152
Start Date
2013-03
Trial ID
NCT01768572
Juvenile Idiopathic Arthritis (JIA) is the most common type of arthritis th...
Status
Recruiting
Location
Phoenix Children's Hospital /ID# 253403
Start Date
2023-10-02
Trial ID
NCT05609630
Treatments Being Tested
This is a multicenter, randomized, double-blind, placebo and tocilizumab co...
Status
Completed
Location
Peking University People's Hospital
Start Date
2022-05-26
Trial ID
NCT05957107
Treatments Being Tested
This phase I trial evaluates the safety and effectiveness of in situ immuno...
Status
Active Not Recruiting
Location
Los Angeles General Medical Center
Start Date
2023-01-09
Trial ID
NCT04616248
This study was designed to evaluate the efficacy of Remdesivir and Bariciti...
Status
Unknown
Location
M. Abdur Rahim Medical College Hospital
Start Date
2020-09-10
Trial ID
NCT04693026
Treatments Being Tested
REMAP-CAP is a randomised, embedded, multifactorial, adaptive platform tria...
Status
Recruiting
Location
University of Florida
Start Date
2016-04-11
Trial ID
NCT02735707
Treatments Being Tested